4D Molecular Therapeutics, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:FDMT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -47.76 M-43.38 M-46.5 M28.55 M-68.13 M -129.45 M Cash from investing activities 31.95 M-13.85 M17.78 M-128.85 M68.89 M -56.03 M Cash from financing activities 318.83 M862 K116 K111.98 M11.48 M 124.44 M Free cash flow -47.76 M-43.38 M-46.5 M28.55 M-68.13 M -129.45 M

News

Strength Seen in 4D Molecular Therapeutics (FDMT): Can Its 7.9% Jump Turn into More Strength?

4D Molecular Therapeutics, Inc. (FDMT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript

4D Molecular Therapeutics, Inc. (FDMT) Presents at Jefferies Global Healthcare Conference 2026 Transcript

4D Molecular Therapeutics, Inc. (FDMT) Presents at Bank of America Global Healthcare Conference 2026 Transcript

4D Molecular Therapeutics, Inc. (FDMT) Reports Q1 Loss, Lags Revenue Estimates

Aclaris Therapeutics (ACRS) Reports Q1 Loss, Beats Revenue Estimates

electroCore (ECOR) Moves 7.1% Higher: Will This Strength Last?

4D Molecular Therapeutics, Inc. (FDMT) Q4 Earnings and Revenues Beat Estimates

4D Molecular Therapeutics, Inc. (FDMT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

4D Molecular Therapeutics, Inc. (FDMT) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:FDMT) 2026-01-19

RBC Capital reiterates Outperform rating on 4D Molecular stock at $32

Ashoo Gupta of 4D Molecular Therapeutics sells $3.3k in FDMT stock